Locus 126: SLC13A5 (17p13.2)
| Meta-analysis summary statistics for associations meeting genome-wide significance |
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs170149 |
citrate |
A/G |
7364 |
0.07 |
0.026 (0.004) |
1.42·10-13 |
show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs170149 |
| Chromosomal location | Chr17: 6,536,654 (17p13.2) |
| Gene (distance) | SLC13A5 (0) |
| Predicted causal gene | SLC13A5 |
| Gene/protein classification | - |
| Metabolite (Pathway) | citrate (Krebs cycle; Energy) |
| Biochemical locus-metabolite relationship | SLC13A5 encodes NaCT, a sodium-coupled citrate transporter [16973915] |
| eQTL associations | - |
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | - |
| Inborn error of metabolism | - |
| Pharmacological information |
| ChEMBL ID | - |
| Drug information |
-
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |